Lung cancer researchers at Winship Cancer Institute of Emory University have discovered a novel strategy to exploit apoptosis, a form of programmed cell death, for the treatment of lung cancer.
Emory Saint Joseph's Hospital is hosting several community events on June 4 and 5 in recognition of National Cancer Survivors' Day. The annual celebration of life honors cancer survivors and is also a gathering of support for families and caregivers.
The Georgia Cancer Registry collects information on each new diagnosis of cancer within the state in order to follow the disease's trends over time and identify patterns.
The tumor monorail project, a collaboration between Georgia Tech, Emory, and Children's Healthcare of Atlanta, will receive a $6.5 million grant from The Marcus Foundation. The project involves the design and testing of a novel device for more efficient treatment of brain tumors.
Carla Berg is trying to think like a tobacco executive. The associate professor in behavioral sciences and health education wants to borrow the sophisticated market segmentation techniques the tobacco industry has used so successfully for decades to lure smokers. Berg, however, plans to use them to identify young tobacco users and convince them to quit.
Two Winship Cancer Institute researchers have received a $3.5 million Informatics Technology for Cancer Research U24 award from the National Cancer Institute.
John Schuerholz, legendary president of the Atlanta Braves, will serve as grand marshal of the Winship Cancer Institute 5K run/walk to be held on Saturday, October 3.
Alpa Patel wants people to stand up. With a Rollins School of Public Health MPH, Patel has focused her research on the role of physical activity in cancer prevention and obesity as a risk factor for cancer. More recently, she has begun looking at possible links between sitting and cancer risk.
An innovative clinical trial using the science of "personalized" cellular therapy has begun enrolling children and adults suffering from graft-versus-host-disease, a life-threatening complication of bone marrow transplantation.
Low doses of the anti-cancer drug imatinib can spur the bone marrow to produce more innate immune cells to fight against bacterial infections, Emory/Winship researchers have found.